NHS England will commission maternal intravenous immunoglobulin for the prevention of allo-immune fetal and neonatal haemochromatosis

NHS England |December 2019 |Maternal intravenous immunoglobulin for the prevention of allo-immune fetal and neonatal haemochromatosis 

NHS England will commission maternal intravenous immunoglobulin (IVIg) for the prevention of allo-immune fetal and neonatal haemochromatosis in accordance with the criteria outlined in this policy.

Clinical Commissioning Policy: Maternal intravenous immunoglobulin for the prevention of allo-immune fetal and neonatal haemochromatosis